A personalized mRNA cancer vaccine succeeded in a late-stage melanoma study, results that could herald a new, powerful approach in oncology.

Phase I results show early promise for a vaccine designed to prevent pancreatic cancer in people at high risk of developing the disease.

If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.

The HPV vaccine for cervical cancer has reduced the risk of dying from the disease before the age of 30 in England to almost zero, the first study of its kind showed Thursday.

Scientists are getting closer to a universal nasal vaccine that could protect against respiratory viruses, bacteria and even allergies

The report, which had cleared the agency’s scientific-review process, had been delayed. It now won’t be published at all, people familiar with the decision told The Post.

Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later.